UK Plans for Robust Life Sciences Regulation Post-Brexit
UK Plans for Robust Life Sciences Regulation Post-Brexit
By: Gareth Rees QC and Wolfgang Schönig
As Brexit is finally completed in the UK, from 1 January 2021, the Medicines and Healthcare products Regulatory Agency (“MHRA”) will be the UK’s standalone medi